ONCS - 1.12 Pre-market at 1.15/1.17 OncoSec Granted Orphan Drug Designation from the U.S. FDA for the Treatment of Unresectable Metastatic Melanoma http://stockcharts.com/c-sc/sc?s=ONCS&p=D&b=5&g=0&i=t94432849817&r=1497011213027 http://stockcharts.com/c-sc/sc?s=ONCS&p=W&b=5&g=0&i=t23545478800&r=1497011234439